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Accumulation of proteins in aberrant conformation occurs in many neurodegenerative
diseases. Furthermore, dysfunctions in protein handling in endoplasmic reticulum (ER)
and the following ER stress have been implicated in a vast number of diseases, such
as amyotrophic lateral sclerosis (ALS). During excessive ER stress unfolded protein
response (UPR) is activated to return ER to its normal physiological balance. The exact
mechanisms of protein misfolding, accumulation and the following ER stress, which could
lead to neurodegeneration, and the question whether UPR is a beneficial compensatory
mechanism slowing down the neurodegenerative processes, are of interest. Protein
disulphide isomerase (PDI) is a disulphide bond-modulating ER chaperone, which can
also facilitate the ER-associated degradation (ERAD) of misfolded proteins. In this review
we discuss the recent findings of ER stress, UPR and especially the role of PDI
in ALS.
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INTRODUCTION
Intracellular protein aggregates are characteristic of neurode-
generative diseases, including amyotrophic lateral sclerosis (ALS;
Ross and Poirier, 2004), the most common motoneuron disease
characterized by a selective death of upper and lower motoneu-
rons. The exact role of protein aggregates in disease pathology is
still under debate (Ross and Poirier, 2005). In ALS the majority
of aggregates are ubiquitinated inclusions (Wood et al., 2003)
typically containing trans-activation response element (TAR)
DNA binding protein 43 (TDP-43; Neumann et al., 2006) and
also mutant Cu, Zn-superoxide dismutase (SOD1) in SOD1-
linked familial ALS (Shibata et al., 1996) and mutant SOD1
mouse (Watanabe et al., 2001) and cell culture models (Lee
et al., 2002). A likely underlying cause for protein accumu-
lation is oxidative stress causing dissociation of SOD1 dimers
to monomers and subsequently leading to aggregation (Rakhit
et al., 2004). This can then together with malfunctioning pro-
teasome degradation machinery contribute to the motoneuron
dysfunction (Marino et al., 2014). Mutant SOD1s have also an
ability to catalyze aberrant oxidative reactions which damages
SOD1 itself (Andrus et al., 1998) possibly resulting in aggregation
of mutant SOD1 (Valentine and Hart, 2003). Recent studies
have further highlighted the importance of protein aggregation,
especially in the case of TDP-43, in ALS pathology, as they
have demonstrated that the induction of autophagy can enhance
the TDP-43 turnover and neuronal survival (Barmada et al.,
2014).
ER STRESS AND UNFOLDED PROTEIN RESPONSE IN ALS
As the first compartment in the secretory pathway, endo-
plasmic reticulum (ER) is responsible for protein synthesis,
posttranslational processing, folding of newly synthesized pro-
teins, and finally delivering the biologically active proteins to their
proper target sites. The rate-limiting step in the secretory pathway
is the transit to Golgi complex. If ER capacity is transcended and
influx to the ER is excessive, the normal physiological state of the
ER is disrupted leading to ER stress. There turn to its normal
physiological balance then requires activation of the unfolded
protein response (UPR) signaling pathway. If the UPR fails to
restore the cell integrity, cell death signaling cascades are activated
and the cell undergoes apoptosis (Schröder and Kaufman, 2005).
Changes in ER morphology have been observed in ALS
patients and the G93A-SOD1 mice (Lautenschlaeger et al., 2012).
G93A-SOD1 mice exhibit dilated rough ER (rER) accompanied
with ribosomal detachment at preclinical and early symptomatic
stages (Dal Canto and Gurney, 1995). Similar findings were
demonstrated in postmortem samples of sporadic ALS (sALS)
patients as researchers reported fragmentation of the rER, irregu-
lar distension of the rER cisternae and a detachment of ribosomes
in degenerating anterior horn cells (Oyanagi et al., 2008). A recent
study demonstrated deposits of granular or amorphous material
in the ER lumen of sALS patients, indicating accumulation of
misfolded proteins which could then in turn cause ER stress
(Sasaki, 2010). In addition, Golgi apparatus become fragmented
both in ALS patients (Fujita et al., 2000) and in G93A-SOD1
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mice (Stieber et al., 2000). Although the results indicate an early
interference in the ER balance, the manifold disease course and
specific disease stage of an individual cell make it difficult to draw
an accurate picture of the ongoing process (Lautenschlaeger et al.,
2012).
CAUSES OF ER STRESS
Accumulation of SOD1 has been considered one of the reasons for
ER stress in ALS, as mutant SOD1 colocalizes with ER markers,
including glucose-related protein 78 (Grp78) and calnexin (Wate
et al., 2005; Kikuchi et al., 2006). Further evidence for linking UPR
to SOD1 accumulation was gained by a discovery that protein
disulphide isomerase (PDI), an ER chaperone, is up-regulated
both in ALS patients and G93A-SOD1 mice (Atkin et al., 2006)
co-localizing with accumulated mutant SOD1 (Atkin et al., 2006).
Mutant SOD1 may interact with Derlin-1 and cause dysregulation
of ER-associated degradation (ERAD), thereby leading to acti-
vation of ER stress-induced apoptosis signal-regulating kinase 1
(ASK1) and apoptosis (Nishitoh et al., 2008).
Another possible cause for ER stress in ALS is the imbalance
of ER calcium homeostasis (Grosskreutz et al., 2010) as protein
processing and folding are calcium dependent (Kuznetsov et al.,
1992). Importantly, decreased ER calcium content contributes to
ER stress in ALS (Jaiswal and Keller, 2009). The ER mitochondria
calcium cycle hypothesis proposes that the increased calcium
release from ER is coupled with calcium uptake by mitochondria
and that calcium is then transported back to ER (Grosskreutz
et al., 2010). This hypothesis could explain why dysfunction in
the mitochondrial calcium storage (Damiano et al., 2006) would
lead to disruption of the ER refilling and subsequently to ER stress
and UPR (Grosskreutz et al., 2010).
UNFOLDED PROTEIN RESPONSE IN ALS
Three major ER stress sensors detect accumulation of unfolded
proteins: double-stranded RNA-activated protein kinase (PKR)-
like ER kinase (PERK), inositol requiring enzyme 1 (IRE1),
and activating transcription factor 6 (ATF6; Schröder and Kauf-
man, 2005). Inositol required enzyme 1 and PERK, are type I
transmembrane proteins with protein kinase activity (Liu et al.,
2002) while ATF6 is a type II transmembrane protein, whose
cytosolic domain can translocate to the nucleus and activate
UPR relevant genes (Haze et al., 1999). While the ER lumi-
nal domains of all three ER stress sensors normally bind to
the ER chaperone GRP78, under ER stress GRP78 dissoci-
ates from these sensors to bind to the misfolded proteins and
enables the activation of UPR sensors (Kaufman, 1999). As
stated before, mutant SOD1 has been demonstrated to bind
to and co-localize with GRP78, which increases its expression
in ALS mice prior to the motor symptoms (Tobisawa et al.,
2003).
THE DOUBLE-STRANDED RNA-ACTIVATED PERK
Dimerization and trans-autophosphorylation result in activation
of the PERK kinase domain (Harding et al., 1999). Activation of
PERK in turn leads to phosphorylation of the eukaryotic initia-
tion factor-2 (eIF2α) inhibiting general translation initiation and
protecting ER against an overload of newly synthesized proteins
(Harding et al., 1999). Paradoxically eIF2α phosphorylation
increases translation of activating transcription factor 4 (Lu
et al., 2004). ER kinase has also another substrate, nuclear factor
erythroid 2-related factor 2 (Nrf2; Cullinan and Diehl, 2006).
ER kinase pathway has been implicated in sALS (Hetz et al.,
2009). Moreover, increased amounts of phospho-PERK-PERK
(Atkin et al., 2006, 2008; Saxena et al., 2009) and phospho-eIF2α
(Saxena et al., 2009) both in G93A-SOD1 mice and Neuro2a cells
transfected with mutant SOD1 have been reported.
INOSITOL REQUIRING ENZYME 1 (IRE1)
Endoplasmic reticulum stress elicits autophosphorylation of
IRE1 inducing its RNAse activity (Liu et al., 2002). IRE1
mediated endoribonuclease activity consequently leads to non-
conventional splicing of XBP1 (X-box binding protein 1; Calfon
et al., 2002). Spliced XBP1 in turn translocates to the nucleus and
controls genes related to protein quality control, protein folding,
components of the ERAD pathway and genes required for lipid
synthesis (Sriburi et al., 2004). Postmortem spinal cord samples
from ALS and ALS mice manifest increased amounts of IRE1.
Interestingly, ALS mice had augmented IRE1 amounts before the
onset of symptoms (Atkin et al., 2006, 2008). Further studies have
revealed up-regulation of phosphorylated IRE1 and increased
amount of spliced XBP1 in G93A-SOD1 mice (Kikuchi et al.,
2006). Accordingly, studies with Neuro2a cells expressing G85R-
SOD1 demonstrated increased splicing and nuclear transloca-
tion of XBP1 mRNA (Oh et al., 2008). The unphosphorylated
and unspliced forms of IRE1 and XBP1 levels are not changed
indicating that these forms could operate as an activable pool
(Lautenschlaeger et al., 2012). Surprisingly, knocking down IRE1
and XBP1 by shRNA in NSC-34 cells transfected with SOD1
mutant caused decreased SOD1 aggregation and improved cell
survival (Hetz et al., 2009). Augmented autophagy has been
hypothesized to be the reason for the protective outcome. Genera-
tion of a knockout/transgenic mouse line by crossbreeding G86R-
SOD1 and XBP1 Nes−/− (Hetz et al., 2008) demonstrated several
autophagic signs further strengthening the autophagy hypothesis.
XBP1 Nes−/−—G86R-SOD1 mice had a slightly prolonged life
span in females whereas males showed no improvement (Hetz
et al., 2009).
THE ACTIVATING TRANSCRIPTION FACTOR 6 (ATF6)
Endoplasmic reticulum stress translocates ATF6 to Golgi appa-
ratus where it is cleaved by two proteases (Haze et al., 1999).
Following cleavage, the cytosolic domain of ATF6 is translocated
to nucleus where it activates UPR-related genes (Gotoh et al.,
2002; Yoshida et al., 2003) Elevated levels of ATF6 have been
reported in ALS patients and G93A-SOD1 mice (Atkin et al., 2006,
2008). In addition, cleavage and translocation of ATF6 in Neuro2a
cells transfected with mutant SOD1 has been verified (Oh et al.,
2008) and knocking down ATF6 in NSC-34 cells transfected
with mutant SOD1 was found to increase SOD1 aggregation
(Hetz et al., 2008). Importantly, mutations in vesicle-associated
membrane protein-associated protein B (VAPB), which have
been connected with late-onset motoneuron disease, associates
with intracellular membranes (Nishimura et al., 2004) as well
as with UPR (Gkogkas et al., 2008). Both native and mutant
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VABP interact with ATF6 and reduce its capability to promote
transcription of XBP1. The mutant VAPB is a much more potent
inhibitor of ATF6 than the wild type VAPB, which may contribute
to the pathological mechanisms of ALS (Gkogkas et al., 2008).
CONTROVERSIAL ROLE OF PDI IN ALS
As seen above, the majority of studies related to UPR in ALS
have concentrated on motoneuronal UPR. However, damaged
white matter has been reported in several neurological disor-
ders (Matute, 2006) and, interestingly, loss of large myelinated
fibers in the corticospinal tracts and ventral roots has been
demonstrated in ALS patients (Underwood et al., 2011). Impor-
tantly, motoneurons that develop ER stress response are coupled
with microglial activation and consequent axonal degeneration
(Saxena et al., 2009). Moreover, up-regulation of UPR markers
PDI and GADD34 have been demonstrated in glial cells in the
spinal cord of G93A-SOD1 mice right after disease onset and
shown segregation of UPR into ventral horn astrocytes and white
matter microglia (Jaronen et al., 2013). This segregation is likely
to reflect variable roles of UPR in astrocytes around degenerating
motoneuron cell bodies and microglia around both motoneu-
ron cell bodies and neurites. In view of the early degenerative
changes in motoneuron axons and the role of microglia in front
line defense, it is not surprising that microglial UPR precedes
and/or dominates over astrocytic UPR during early motoneuron
degeneration.
PDI INACTIVATION MAY CONTRIBUTE TO PROTEIN AGGREGATION
Protein disulphide isomerase is an enzyme of a thioredoxin
superfamily primarily functioning in the ER as a chaperone
protein. It facilitates the rearrangements of disulphide bonds via
catalysis of thiol-disulphide exchange (Wilkinson and Gilbert,
2004; Ellgaard and Ruddock, 2005). In addition to its well-
known role in the ER, PDI has been found in other cellu-
lar localizations, such as cytosol and mitochondria, where its
physiological role is not yet completely clear (Rigobello et al.,
2001; Turano et al., 2002; Wilkinson and Gilbert, 2004). How-
ever, the mitochondrion-associated PDI can induce apoptosis
through mitochondrial outer membrane permeabilization when
accumulating at high levels in response to misfolded proteins
(Hoffstrom et al., 2010). Up-regulation of PDI has been demon-
strated in ALS (Atkin et al., 2006, 2008). In G93A-SOD1 rats
PDI expression is increased early in the disease progression
declining sharply towards the end stage (Ahtoniemi et al., 2008).
The up-regulation of PDI in the early symptomatic stages of
ALS (Ahtoniemi et al., 2008) might be due to the attempt to
resolve the misfolding and aggregating SOD1, but as the oxida-
tive damage increases (Goldsteins et al., 2008) PDI becomes
oxidized and loses its ability to function as a disulphide bond-
rearranging enzyme (Figure 1). Recent report has demonstrated
that S-nitrosylated and inactivated PDI can increase mutant
SOD1 aggregation and trigger neuronal cell death (Jeon et al.,
2014).
PDI UPREGULATION MAY CAUSE NOX ACTIVATION
Regardless of the fact that PDI is generally thought to act
as a compensatory survival supporting enzyme, the other side
of the PDI coin might not be as beneficial as once assumed.
Recent studies have shown that in non-neuronal cells, such as
vascular cells and peripheral macrophages, PDI is associated
with NADPH oxidase (NOX) and act as a redox-sensitive reg-
ulatory protein of several NOX isoforms (Janiszewski et al.,
2005; Laurindo et al., 2008; Santos et al., 2009a). NADPH oxi-
dase is an enzyme that generates superoxide by transferring
electrons from NADPH inside the cell across the membrane
and coupling these to molecular oxygen to produce superox-
ide anion, a reactive free-radical. Indeed, in vivo ALS studies
indicate that NOX activation and superoxide production are
elevated in microglia and may contribute to motoneuron death
(Wu et al., 2006). Furthermore, ER stress capable of induc-
ing UPR has been previously shown to result in NOX activa-
tion, leading to increased superoxide production in peripheral
macrophages (Li et al., 2010). As UPR has been demonstrated
in microglia in the spinal cords of G93A-SOD1 mice (Jaronen
et al., 2013), we hypothesize that PDI activity might be coupled
to NOX-mediated reactive oxygen species (ROS) production dur-
ing UPR. The view is supported by the finding that induction
of UPR results in NOX activation and this activation is PDI-
dependent (Jaronen et al., 2013). Moreover, siRNA-mediated
down-regulation of PDI expression was found to reduce NOX
activation. Similar results were obtained when human primary
monocytes, rat primary microglia and murine macrophage type
of cells were used. These in vitro data suggest that PDI is a
significant regulator of UPR-induced NOX activation in cells
of hematopoietic origin. Transient expression of G93A-SOD1
inflicted augmented NOX activation in microglia BV-2 cells
suggesting that mutant SOD1 is capable of triggering the UPR
and finally superoxide production (Figure 1). Although several
models have been proposed where PDI interacts with catalytical
or regulatory subunits of NOX (Laurindo et al., 2008), the exact
mechanism of how PDI activates NOX remains unclear. Based on
the current knowledge PDI reductase activity may be required as
bacitracin, an inhibitor of PDI reductase activity (Dickerhof et al.,
2011), is able to suppress superoxide production in several cell
types.
EXCESSIVE PDI CATALYZED REFOLDING MAY CONTRIBUTE TO
OXIDATIVE STRESS
The main site of PDI function is the ER, where the redox
conditions are very different from cytosol, enabling the protein
folding. Glutathione is one of the key players in controlling the
redox status of ER as it has been shown that glutathione can
provide oxidizing equivalents for disulphide formation (Hwang
et al., 1992). However, oxidoreductin Ero1 is thought to act as
a primary electron acceptor in the disulphide bond formation,
transferring oxidizing equivalent to its substrate PDI (Sevier
et al., 2007). Ero1 oxidizes the active cysteinyl thiol groups
in PDI, enabling it then in turn to oxidize the client protein
and create a disulphide bond. As Ero1 acts as an acceptor of
electrons from PDI, it passes the electrons to molecular oxygen
creating harmful hydroperoxide (Figure 1; Higa and Chevet,
2012). Furthermore, reduced glutathione may be necessary for
isomerization of improper disulphide bonds, resulting in oxidized
glutathione (Margittai and Bánhegyi, 2010). These hydroperoxide
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FIGURE 1 | The role of PDI in ALS. At the early stages of ALS, PDI
can prevent SOD1 aggregation by re-assembling SOD1 to its active
form. Protein disulphide isomerase inactivation by S-nitrosylation
increases ER stress (1). Further on in the disease, the aggregation of
SOD1 can lead to ER stress following UPR. Interestingly, augmented
UPR can result in increased PDI activation. This can in turn result in
NOX activation, leading to increased superoxide production and finally
neurotoxicity (2). The second possible route for PDI-related neurotoxicity
is through ERO1α; PDI activity will activate ERO1α, which will then in
turn produce hydroperoxide and result in neurotoxicity (3).
and oxidized glutathione byproducts are thought to be dangerous
(Tu and Weissman, 2002; Margittai and Bánhegyi, 2010) and
form a link between ER stress and oxidative stress (Harding
et al., 2003; Haynes et al., 2004; Malhotra et al., 2008). How-
ever, no clear consensus on whether the Ero1-mediated extensive
oxidation in the ER leads to augmented oxidative stress or acts
as a part of homeostatic redox control mechanisms, has been
reached (Appenzeller-Herzog, 2011). Interestingly, a recent study
by Shepherd et al. (2014) shed more light over the companion-
ship of PDI and Ero1, demonstrating that PDI has ability to
catalyze both the activation and inactivation of its own catalyst
Ero1.
CONCLUSION
Endoplasmic reticulum stress is a characteristic of neurodegen-
erative diseases, including ALS. While UPR is thought to be
an adaptive and protective reaction of cells to overwhelming
ER stress, the cellular response triggered by protein aggregation
and UPR together may lead to misbalance in protein folding
pathway and result in increased ROS production. The follow-
ing increased oxidative stress upon UPR can be regarded as a
union of a number of both proapoptotic and proadaptive mech-
anisms (Santos et al., 2009b), increased PDI expression being
an integral part of the latter. However, keeping in mind that
high levels of PDI in response to misfolded proteins, is also
capable of promoting a cell death cascade (Hoffstrom et al., 2010),
the control of PDI expression offers an interesting therapeutic
strategy. In microglia cells ROS production may indeed depend
on PDI, which associates with NOX and regulates its function.
In agreement with our findings, recent studies have shown that
overexpression of PDI promotes NOX activation in vascular
smooth muscle cells (Fernandes et al., 2009). Furthermore, our
notion is also supported by findings that PDI closely associates
with p22phox subunit of phagocyte NOX, and that NOX activa-
tion directly correlates with PDI expression levels (Santos et al.,
2009a). Currently the main scope for the role of PDI in protein
aggregation linked neurodegeneration has been focused at its
function in maintenance of native protein structure in neurons.
Nevertheless upon excessive protein misfolding the penalty of
oxidative stress originating from oxidative folding may exceed ER
adaptive capabilities in neuronal cells and cause aberrant NOX
activation in microglia.
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